Mechanism of Neiyi Kangfu Tablets in treatment of adenomyosis through regulating GPER-Ras-STAT3 signal pathway
10.3969/j.issn.1001-1528.2017.04.001
- VernacularTitle:内异康复片调控GPER-Ras-STAT3通路治疗子宫腺肌病的机制
- Author:
Tingting FENG
;
Ye WANG
;
Liyuan QU
;
Xiaoxue FAN
;
Meiling ZENG
;
Shaobin WEI
- Keywords:
adenomyosis;
Neiyi Kangfu Tablets;
GPER-Ras-STAT3 pathway;
mechanism
- From:
Chinese Traditional Patent Medicine
2017;39(4):665-671
- CountryChina
- Language:Chinese
-
Abstract:
AIM To study the therapeutic effects of Neiyi Kangfu Tablets (Trionycis Carapax,Ostreae concha,Rhei Radix et Rhizoma,etc.) on adenomyosis and its possible mechanism of action.METHODS The mouse model for adenomyosis was set up by the pituitary allograft,and received the gavage of Neiyi Kangfu Tablets,Dan'e Fukang Decoction (Salviae miltiorrhizae Radix et Rhizoma,Curcumae Rhizoma,Paeoniae Radix rubra,etc.) and gestrinone,respectively,for three months.Western blot,real-time PCR,IHC were used to measure the expression of GPER-Ras-STAT3 in ectopic endometrium and entopic endometrium.RESULTS High doses of Neiyi Kangfu Tablets could significantly lower GPER protein and gene expression;down-regulate the Ras and STAT3 protein expression;reduce the lesion severity score of ectopic tissue morphology.Its curative effect was better than Dan'e Fukang Decoction and gestrinone.CONCLUSION Neiyi Kangfu Tablets may control the development of ectopic lesions by inhibiting the GPER-Ras-STAT3 pathway activity and weakening the production of estrogen.
